FDA Says It Won’t Act On Abortion Drugs Till March, 2 Years After Pledging To Review Safety Concerns
The USDA plans to finalize its safety review of the most prolific abortion pills on the market, but it won’t do so until March 2027.
Congressional Laziness About To Restart Taxpayer Funds For Biggest U.S. Abortion And Transgender Kids Mill
Planned Parenthood has expanded into "transgender medicine" in a big way and Congress should cut any future federal funding.